(19)
(11)EP 2 292 750 A3

(12)EUROPEAN PATENT APPLICATION

(88)Date of publication A3:
21.12.2011 Bulletin 2011/51

(43)Date of publication A2:
09.03.2011 Bulletin 2011/10

(21)Application number: 10191975.1

(22)Date of filing:  30.07.2004
(51)International Patent Classification (IPC): 
C12N 9/90(2006.01)
C12N 15/82(2006.01)
C07K 5/04(2006.01)
C12N 15/61(2006.01)
C07K 5/00(2006.01)
C12N 9/00(2006.01)
(84)Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(62)Application number of the earlier application in accordance with Art. 76 EPC:
04786144.8 / 1786831

(71)Applicant: Novozymes A/S
2880 Bagsvaerd (DK)

(72)Inventors:
  • Jessen, Holly J.
    Chanhassen, MN 55317 (US)
  • Gokarn, Ravi R.
    Omaha, NE 68130 (US)
  • Gort, Steven J.
    Apple Valley, MN 55124 (US)
  • Selifonova, Olga V.
    Plymouth, MN 55446 (US)
  • Liao, Hans H.
    Eden Prairie, MN 55347 (US)
  • Brazeau, Brian J.
    Oskaloosa, IA 52577  (US)

(74)Representative: Gowshall, Jonathan Vallance 
Forrester & Boehmert Pettenkoferstrasse 20-22
80336 München
80336 München (DE)

  


(54)Alanine 2, 3 aminomutases


(57) Alanine 2,3-aminomutase sequences are disclosed, as are cells having alanine 2,3-aminomutase activity and methods of selecting for such cells. Methods for producing beta-alanine, panthothenate, 3-hydroxypropionic acid, as well as other organic compounds, are disclosed.





Search report